产品编号 :
Cas No. :
CAS No. |
1123838-51-6 |
|---|---|
中文名称 |
格列沙替尼盐酸盐 |
英文名称 |
Glesatinib HCl |
别名 |
Glesatinib (hydrochloride);Glesatinib HCl;MGCD-265 HYDROCHLORIDE;CS-2642;Glesatinib (hydrochloride)(MGCD265 hydrochloride) |
标准英文名 |
N-((3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-(4-fluorophenyl)acetamide hydrochloride |
MDL No. |
MFCD30344661 |
分子式 |
C31H28ClF2N5O3S2 |
分子量 |
656.18 |
精确分子量 |
655.13 |
SMILES |
O=C(NC(NC1=CC=C(OC2=C3C(C=C(C4=NC=C(CNCCOC)C=C4)S3)=NC=C2)C(F)=C1)=S)CC5=CC=C(F)C=C5.Cl |
标准SMILES |
Cl.COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=CC=C(C=C3F)NC(=S)NC(=O)CC3=CC=C(F)C=C3)=C2S1 |
用途 |
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET and SMO; it acts as a tyrosine kinase inhibitor and antagonizes P-glycoprotein-mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). |
InChIKey |
TUVXGVPWXBWWEP-UHFFFAOYSA-N |
|
|
评论 |
|---|